{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:36:34Z","timestamp":1768880194870,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1748-717x-9-208","type":"journal-article","created":{"date-parts":[[2014,10,20]],"date-time":"2014-10-20T15:01:26Z","timestamp":1413817286000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Proposed salvage treatment strategy for biochemical failure after radical prostatectomy in patients with prostate cancer: a retrospective study"],"prefix":"10.1186","volume":"9","author":[{"given":"Makito","family":"Miyake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobumichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Asakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Morizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Anai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Torimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyohide","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,20]]},"reference":[{"key":"1185_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1097\/01.ju.0000081200.63275.0b","volume":"170","author":"MR Cooperberg","year":"2003","unstructured":"Cooperberg MR, Lubeck DP, Penson DF, Mehta SS, Carroll PR, Kane CJ: Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE. J Urol 2003, 170: 905-908. 10.1097\/01.ju.0000081200.63275.0b","journal-title":"J Urol"},{"key":"1185_CR2","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/jjco\/hyq008","volume":"40","author":"N Tanaka","year":"2010","unstructured":"Tanaka N, Fujimoto K, Hirayama A, Yoneda T, Yoshida K, Hirao Y: Trends of the primary therapy for patients with prostate cancer in Nara urooncological research group (NUORG): a comparison between the CaPSURE data and the NUORG data. Jpn J Clin Oncol 2010, 40: 588-592. 10.1093\/jjco\/hyq008","journal-title":"Jpn J Clin Oncol"},{"key":"1185_CR3","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1186\/1471-2407-13-588","volume":"13","author":"N Tanaka","year":"2013","unstructured":"Tanaka N, Hirayama A, Yoneda T, Yoshida K, Shimada K, Konishi N, Fujimoto K: Trends of risk classification and primary therapy for Japanese patients with prostate cancer in Nara Uro-Oncological Research Group (NUORG)\u2013a comparison between 2004\u20132006 and 2007\u20132009. BMC Cancer 2013, 13: 588. 10.1186\/1471-2407-13-588","journal-title":"BMC Cancer"},{"key":"1185_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2490-11-6","volume":"11","author":"N Tanaka","year":"2011","unstructured":"Tanaka N, Fujimoto K, Hirayama A, Samma S, Momose H, Kaneko Y, Haramoto M, Hayashi Y, Nakagawa Y, Otani T, Watanabe S, Hirao Y: The primary therapy chosen for patients with localized prostate cancer between the university hospital and its affiliated hospitals in Nara Uro-Oncological Research Group registration. BMC Urol 2011, 11: 6. 10.1186\/1471-2490-11-6","journal-title":"BMC Urol"},{"key":"1185_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10147-011-0226-2","volume":"16","author":"N Tanaka","year":"2011","unstructured":"Tanaka N, Fujimoto K, Hirayama A, Samma S, Momose H, Kaneko Y, Haramoto M, Hayashi Y, Nakagawa Y, Otani T, Watanabe S, Hirao Y: Risk-stratified survival rates and predictors of biochemical recurrence after radical prostatectomy in a Nara, Japan, cohort study. Int J Clin Oncol 2011, 16: 553-559. 10.1007\/s10147-011-0226-2","journal-title":"Int J Clin Oncol"},{"key":"1185_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/1477-7819-10-249","volume":"10","author":"E Okajima","year":"2012","unstructured":"Okajima E, Yoshikawa M, Masuda Y, Shimizu K, Tanaka N, Hirayama A, Shimada K, Fujimoto K, Hirao Y: Improvement of the surgical curability of locally confined prostate cancer including non-organ-confined high-risk disease through retropubic radical prostatectomy with intentional wide resection. World J Surg Oncol 2012, 10: 249. 10.1186\/1477-7819-10-249","journal-title":"World J Surg Oncol"},{"key":"1185_CR7","doi-asserted-by":"publisher","first-page":"204215","DOI":"10.1155\/2012\/204215","volume":"2012","author":"N Tanaka","year":"2012","unstructured":"Tanaka N, Fujimoto K, Hirayama A, Nakai Y, Chihara Y, Anai S, Tomioka A, Shimada K, Konishi N, Hirao Y: Calculated tumor volume is an independent predictor of biochemical recurrence in patients who underwent retropubic radical prostatectomy. Adv Urol 2012, 2012: 204215.","journal-title":"Adv Urol"},{"key":"1185_CR8","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0094-0143(05)70163-4","volume":"28","author":"M Han","year":"2001","unstructured":"Han M, Partin AW, Pound CR, Epstein JI, Walsh PC: Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: the 15-year Johns Hopkins experience. Urol Clin North Am 2001, 28: 555-565. 10.1016\/S0094-0143(05)70163-4","journal-title":"Urol Clin North Am"},{"key":"1185_CR9","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1200\/JCO.2006.09.6495","volume":"25","author":"GP Swanson","year":"2007","unstructured":"Swanson GP, Hussey MA, Tangen CM, Chin J, Messing E, Canby-Hagino E, Forman JD, Thompson IM, Crawford ED: Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794. J Clin Oncol 2007, 25: 2225-2229. 10.1200\/JCO.2006.09.6495","journal-title":"J Clin Oncol"},{"key":"1185_CR10","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1200\/JCO.2006.10.4067","volume":"25","author":"TH Van der Kwast","year":"2007","unstructured":"Van der Kwast TH, Bolla M, Van Poppel H, Van Poppel H, Van Cangh P, Vekemans K, Da Pozzo L, Bosset JF, Kurth KH, Schr\u00f6der FH, Collette L: Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911. J Clin Oncol 2007, 25: 4178-4186. 10.1200\/JCO.2006.10.4067","journal-title":"J Clin Oncol"},{"key":"1185_CR11","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1200\/JCO.2008.18.9563","volume":"27","author":"T Wiegel","year":"2009","unstructured":"Wiegel T, Bottke D, Steiner U, Siegmann A, Golz R, St\u00f6rkel S, Willich N, Semjonow A, Souchon R, St\u00f6ckle M, R\u00fcbe C, Weissbach L, Althaus P, Rebmann U, K\u00e4lble T, Feldmann HJ, Wirth M, Hinke A, Hinkelbein W, Miller K: Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02\/AUO AP 09\/95. J Clin Oncol 2009, 27: 2924-2930. 10.1200\/JCO.2008.18.9563","journal-title":"J Clin Oncol"},{"key":"1185_CR12","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1001\/jama.299.23.2760","volume":"299","author":"BJ Trock","year":"2008","unstructured":"Trock BJ, Han M, Freedland SJ, Humphreys EB, DeWeese TL, Partin AW, Walsh PC: Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA 2008, 299: 2760-2769. 10.1001\/jama.299.23.2760","journal-title":"JAMA"},{"key":"1185_CR13","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1200\/JCO.2003.12.043","volume":"21","author":"MS Katz","year":"2003","unstructured":"Katz MS, Zelefsky MJ, Venkatraman ES, Fuks Z, Hummer A, Leibel SA: Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer. J Clin Oncol 2003, 21: 483-489. 10.1200\/JCO.2003.12.043","journal-title":"J Clin Oncol"},{"key":"1185_CR14","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1200\/JCO.2006.08.9607","volume":"25","author":"AJ Stephenson","year":"2007","unstructured":"Stephenson AJ, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, Klein EA, Anscher MS, Michalski JM, Sandler HM, Lin DW, Forman JD, Zelefsky MJ, Kestin LL, Roehrborn CG, Catton CN, DeWeese TL, Liauw SL, Valicenti RK, Kuban DA, Pollack A: Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 2007, 25: 2035-2041. 10.1200\/JCO.2006.08.9607","journal-title":"J Clin Oncol"},{"key":"1185_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.urolonc.2007.04.006","volume":"26","author":"M Sia","year":"2008","unstructured":"Sia M, Pickles T, Morton G, Souhami L, Lukka H, Warde P: Salvage radiotherapy following biochemical relapse after radical prostatectomy: proceedings of the Genito-Urinary Radiation Oncologists of Canada consensus meeting. Urol Oncol 2008, 26: 271-275. 10.1016\/j.urolonc.2007.04.006","journal-title":"Urol Oncol"},{"key":"1185_CR16","volume-title":"TNM Classification of Malignant Tumours","year":"2002","unstructured":"Sobin LH, Wittekind CH (Eds): TNM Classification of Malignant Tumours. 6th edition. New York: Wiley-Liss; 2002.","edition":"6"},{"key":"1185_CR17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.6004\/jnccn.2010.0012","volume":"8","author":"J Mohler","year":"2000","unstructured":"Mohler J, Bahnson RR, Boston B, Kantoff P, Kozlowski JM, Kuettel M, Lange PH, Logothetis C, Pow-Sang JM, Roach M 3rd, Sandler H, Scardino PT, Taylor RJ, Urban DA, Walsh PC, Wilson TG: NCCN clinical practice guidelines in oncology: prostate cancer. J Natl Compr Canc Netw 2000, 8: 162-200.","journal-title":"J Natl Compr Canc Netw"},{"key":"1185_CR18","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1001\/jama.281.17.1591","volume":"281","author":"CR Pound","year":"1999","unstructured":"Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC: Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999, 281: 1591-1597. 10.1001\/jama.281.17.1591","journal-title":"JAMA"},{"key":"1185_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0090-4295(02)02397-X","volume":"61","author":"CS Higano","year":"2003","unstructured":"Higano CS: Side effects of androgen deprivation therapy: monitoring and minimizing toxicity. Urology 2003, 61: 32-38. 10.1016\/S0090-4295(02)02397-X","journal-title":"Urology"},{"key":"1185_CR20","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/jjco\/hyr005","volume":"41","author":"K Torimoto","year":"2011","unstructured":"Torimoto K, Samma S, Kagebayashi Y, Chihara Y, Tanaka N, Hirayama A, Fujimoto K, Hirao Y: The effects of androgen deprivation therapy on lipid metabolism and body composition in Japanese patients with prostate cancer. Jpn J Clin Oncol 2011, 41: 577-581. 10.1093\/jjco\/hyr005","journal-title":"Jpn J Clin Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-9-208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T07:10:07Z","timestamp":1630566607000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-9-208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,20]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1185"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-9-208","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,20]]},"assertion":[{"value":"10 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"208"}}